CoChat

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer

Open access
Shu, Shaokun, Wu, Hua-Jun, Ge, Jennifer Y., Zeid, Rhamy, Harris, Isaac S., Jovanović, Bojana, Murphy, Katherine, Wang, Binbin, Qiu, Xintao, Endress, Jennifer E., Reyes, Jaime, Lim, Klothilda, Font-Tello, Alba, Syamala, Sudeepa, Xiao, Tengfei, Reddy Chilamakuri, Chandra Sekhar, Papachristou, Evangelia K., D’Santos, Clive, Anand, Jayati, Hinohara, Kunihiko, Li, Wei, McDonald, Thomas O., Luoma, Adrienne, Modiste, Rebecca J., Nguyen, Quang-De, Michel, Brittany, Cejas, Paloma, Kadoch, Cigall, Jaffe, Jacob D., Wucherpfennig, Kai W., Qi, Jun, Liu, X. Shirley, Long, Henry, Brown, Myles, Carroll, Jason S., Brugge, Joan S., Bradner, James, Michor, Franziska, Polyak, Kornelia · 2020 · Molecular Cell
Cited by 202

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

SUMMARY BET bromodomain inhibitors (BBDI) are candidate therapeutic agents in triple-negative breast cancer (TNBC) and other cancer types, but inherent and acquired resistance to BBDIs limit their potential clinical use. Using CRISPR and small molecule inhibitor screens combined with comprehensive molecular profiling of BBDI response and resistance, we identified synthetic lethal interactions with BBDIs and genes that when deleted confer resistance. We observed synergy with regulators of cell cycle progression, YAP, AXL, and SRC signaling, and chemotherapeutic agents. We also uncovered functional similarities and differences among BRD2, BRD4, and BRD7; while deletion of BRD2 and BRD4 enhances sensitivity to BBDIs, BRD7 loss leads to gain of TEAD/YAP chromatin binding and luminal features associated with BBDI resistance. Single cell RNA-seq and ATAC-seq and cellular barcoding analysis of BBDI responses in sensitive and resistant cell lines highlight significant heterogeneity among samples and demonstrate that BBDI resistance can be either pre-existing or acquired.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2020.04.027

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 202

Metadata

Authors
Shu, S., Wu, H.-J., Ge, J. Y., Zeid, R., Harris, I. S., Jovanović, B., Murphy, K., Wang, B., Qiu, X., Endress, J. E., Reyes, J., Lim, K., Font-Tello, A., Syamala, S., Xiao, T., Reddy Chilamakuri, C. S., Papachristou, E. K., D’Santos, C., Anand, J., Hinohara, K., Li, W., McDonald, T. O., Luoma, A., Modiste, R. J., Nguyen, Q.-D., Michel, B., Cejas, P., Kadoch, C., Jaffe, J. D., Wucherpfennig, K. W., Qi, J., Liu, X. S., Long, H., Brown, M., Carroll, J. S., Brugge, J. S., Bradner, J., Michor, F., & Polyak, K.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2020-06
Volume
78
Issue
6
Pages
1096-1113.e8
ISSN
1097-2765 (ISSN-L)
OpenAlex
W3025750971
Cited by
202
References
25
FWCI
8.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. https://app.cochat.ai/papers/10.1016/j.molcel.2020.04.027
The paper
Shu, S., Wu, H.-J., Ge, J. Y., Zeid, R., Harris, I. S., Jovanović, B., Murphy, K., Wang, B., Qiu, X., Endress, J. E., Reyes, J., Lim, K., Font-Tello, A., Syamala, S., Xiao, T., Reddy Chilamakuri, C. S., Papachristou, E. K., D’Santos, C., Anand, J., . . . Polyak, K. (2020). Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Molecular Cell. https://doi.org/10.1016/j.molcel.2020.04.027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.